Hindustan Agrigenetics board to meet on May 30

1 min read     Updated on 21 May 2026, 06:26 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Hindustan Agrigenetics Limited board meets on May 30, 2026, to consider audited FY26 results. Trading window closed until 48 hours post-filing.

powered bylight_fuzz_icon
40913770

*this image is generated using AI for illustrative purposes only.

Hindustan Agrigenetics Limited has announced that its board of directors will meet on Saturday, May 30, 2026. The primary agenda of the meeting is to consider and approve the audited financial results of the company for the quarter and financial year ended March 31, 2026. The meeting is being convened in compliance with Regulation 29 of the SEBI (LODR) Regulations, 2015.

Board Meeting Agenda

The board will deliberate on the audited financial statements for the specified period. The approval of these results is a statutory requirement and will be followed by the necessary filings with the stock exchanges.

Trading Window Closure

In line with regulatory norms, the trading window for dealing in the securities of the company remains closed. This restriction applies to all directors, officers, designated persons, and their immediate relatives. The window will stay shut until the end of 48 hours after the audited financial results for the quarter and financial year ended March 31, 2026 are approved by the board and filed with the stock exchange.

Company Information

Detail Information
Company Name Hindustan Agrigenetics Limited
CIN L01119DL1990PLC040979
ISIN INE092301014
Registered Office C-1/5, Second Floor, Safdarjung Development Area, Hauz Khas, New Delhi-110016

The intimation was sent to BSE Limited on May 21, 2026, by Rajendra Naniwadekar, Managing Director of the company.

How have Hindustan Agrigenetics Limited's revenue and profitability trends evolved over the past few fiscal years, and what growth trajectory might the FY2026 results reveal?

What strategic initiatives or expansion plans is Hindustan Agrigenetics likely to announce alongside its FY2026 financial results that could impact its stock performance?

How might the company's financial results compare to peers in the agrigenetics and agri-biotech sector, and what does this indicate about its competitive positioning?

Hindustan Agrigenetics Limited Files Yearly SEBI SAST Disclosure for FY26

1 min read     Updated on 07 Apr 2026, 04:31 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Hindustan Agrigenetics Limited submitted its yearly SEBI SAST disclosure for FY26 ended March 31, 2026, confirming no encumbrance on promoter shares. Managing Director Rajendra Naniwadekar filed the declaration under Regulation 31(4) on April 07, 2026, ensuring compliance with substantial acquisition regulations. The disclosure covers both promoter and promoter group members, maintaining transparency in shareholding activities.

powered bylight_fuzz_icon
37105287

*this image is generated using AI for illustrative purposes only.

Hindustan Agrigenetics Limited has filed its mandatory yearly disclosure under SEBI's Substantial Acquisition of Shares & Takeovers (SAST) Regulations with BSE Limited for the financial year ended March 31, 2026. The disclosure, submitted on April 07, 2026, confirms compliance with regulatory requirements for promoter shareholding transparency.

Regulatory Compliance Details

The disclosure was filed under Regulation 31(4) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The document was submitted to BSE Limited's Department of Corporate Services for the company's scrip code 519574.

Parameter: Details
Regulation: SEBI SAST Regulation 31(4)
Financial Year: Ended March 31, 2026
Filing Date: April 07, 2026
Scrip Code: 519574

Promoter Declaration

Rajendra Naniwadekar, Managing Director and Promoter of hindustan agrigenetics , provided a formal declaration regarding promoter shareholding activities during FY26. The declaration specifically addressed encumbrance activities by promoter and promoter group members.

Key Disclosure Statement

The promoter declaration confirmed that no encumbrance was made, directly or indirectly, over the company's shares during the financial year ended March 31, 2026. This declaration covers both the promoter and all promoter group members, ensuring complete transparency in shareholding activities.

Disclosure Aspect: Status
Promoter Encumbrance: None
Promoter Group Encumbrance: None
Period Covered: FY26 (April 2025 - March 2026)
Declaration Authority: Managing Director

Corporate Information

The disclosure was signed digitally by Rajendra Naniwadekar, who serves as Managing Director with DIN 00032107. The company maintains its registered office at C-1/5, Second Floor, Safdarjung Development Area, Hauz Khas, New Delhi-110016, with correspondence address at C 63, South Extension Part-II, New Delhi 110 049. The filing represents the company's ongoing commitment to regulatory compliance and corporate governance standards under SEBI guidelines.

What strategic initiatives might Hindustan Agrigenetics pursue in FY27 given the clean promoter shareholding structure?

Could the absence of promoter encumbrances signal potential fundraising or expansion plans through equity dilution?

How might this transparent shareholding position impact institutional investor confidence in the agrigenetics sector?

More News on Hindustan Agrigenetics